Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $520.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price target suggests a potential upside of 14.74% from the company’s […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price target suggests a potential upside of 14.74% from the company’s […]
